SCHEMBL6300838

SCHEMBL6300838

O=C(O)c1c(-c2cccc(F)c2)[nH]c2ccc(Cl)cc2c1=O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.56
KMT2A Q03164 3/20 0.56
ALDH1A1 P00352 2/20 0.56
THRB P10828 1/20 0.56
MAP2 P11137 3/20 0.49
PDE10A Q9Y233 1/20 0.48
CA1 P00915 1/20 0.48
CA2 P00918 1/20 0.48
RXFP1 Q9HBX9 1/20 0.46
KDM4E B2RXH2 1/20 0.45
TUBB4A P04350 1/20 0.45
TUBB P07437 1/20 0.45
TUBA3C P0DPH7 1/20 0.45
TUBA1B P68363 1/20 0.45
TUBA4A P68366 1/20 0.45
TUBB4B P68371 1/20 0.45
TUBB3 Q13509 1/20 0.45
TUBB2A Q13885 1/20 0.45
TUBB8 Q3ZCM7 1/20 0.45
TUBA3E Q6PEY2 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6294977 0.91 ALDH1A1 (0.48) MEN1KMT2AALDH1A1THRBMAP2
SCHEMBL6295661 0.91 MAP2 (0.52) MEN1KMT2AALDH1A1MAP2PDE10A
SCHEMBL25200113 0.91 MEN1 (0.47) MEN1KMT2AALDH1A1THRBMAP2
SCHEMBL6294973 0.91 ALDH1A1 (0.52) MEN1KMT2AALDH1A1THRBMAP2
SCHEMBL6300664 0.88 PDE10A (0.60) MEN1KMT2AALDH1A1MAP2PDE10A
SCHEMBL25198348 0.86 CCNT1 (0.45) MEN1KMT2AMAP2PDE10ACA1
SCHEMBL25210308 0.85 MAP2 (0.46) MEN1KMT2AALDH1A1THRBMAP2
SCHEMBL25199917 0.84 KDM4E (0.42) MEN1KMT2AALDH1A1THRBMAP2
SCHEMBL6294965 0.83 SERPINE1 (0.49) MEN1KMT2AMAP2PDE10ATUBB4A
SCHEMBL6296013 0.83 ALDH1A1 (0.60) ALDH1A1KDM4ETUBB4ATUBBTUBA3C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6897316-B2 Substituted 2-phenyl-4-quinolone-3-carboxylic acid compounds and their use as antitumor agents CHINA MEDICAL UNIVERSITY (TW) 2005-05-24 US disclosed
US-20050032832-A1 Substituted 2-phenyl-4-quinolone-3-carboxylic acid compounds and their use as antitumor agents CHINA MEDICAL UNIVERSITY (TW) 2005-02-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050032832-A1 Substituted 2-phenyl-4-quinolone-3-carboxylic acid compounds and their use as antitumor agents TP53, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, CHUK MEN1 3877/4885KMT2A 780/4885ALDH1A1 465/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.